Yang Xin, Hong Canhui, Guan Tangfei, Zhang Chenggui, Yang Yongshou, Xiao Peiyun, Xiao Huai, He Zhengchun
Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University, Dali 671000, China.
National-Local Joint Engineering Research Center of Entomoceutics, Dali 671000, China.
Biology (Basel). 2025 May 22;14(6):589. doi: 10.3390/biology14060589.
Ischemic stroke (IS) is a high-mortality, multi-complication cardiovascular disease. Reducing brain injury and promoting neuronal repair after IS onset remain important challenges for current treatments. Our team previously found that PAS840, an extract from (L.), protects nerve function; this study further uses LC-MS/MS and peptidomics to analyze PAS840's components and network pharmacology to predict its ischemic stroke (IS) therapeutic targets. We then employed Transwell, a biochemical kit, real-time quantitative polymerase chain reaction (RT-qPCR), and transcriptomics to investigate PAS840's effects on migration ability, oxidative stress levels, and cellular pathways in mouse microglial cells (BV-2) following oxygen-glucose deprivation/reoxygenation (OGD/R) injury. Finally, using Evans blue staining, immunohistochemical analysis, and RT-qPCR, we investigated PAS840's effects on the blood-brain barrier, inflammation pathways, and neural function in a transient middle cerebral artery occlusion (tMCAO) rat model. PAS840 components target multiple IS pathways, effectively inhibit NF-κB/NLRP3/Caspase-1/IL-1β inflammasome pathway activation in BV-2 cells following OGD/R, reduce cellular oxidative stress, inflammation, and pyroptosis, and improve cell viability and migration ability. PAS840 decreases NF-κB/NLRP3/Caspase-1/IL-1β inflammasome pathway expression in tMCAO rat brains, reduces inflammation, activates BDNF/VGF/NGR1/Erbb4 neurotrophic factor and vascular endothelial growth factor pathways, enhances neuronal cell viability, and effectively protects and repairs the blood-brain barrier.
缺血性中风(IS)是一种高死亡率、多并发症的心血管疾病。减少IS发病后的脑损伤并促进神经元修复仍然是当前治疗面临的重要挑战。我们的团队之前发现,来自[植物名称]的提取物PAS840可保护神经功能;本研究进一步使用液相色谱-串联质谱(LC-MS/MS)和肽组学分析PAS840的成分,并利用网络药理学预测其缺血性中风(IS)的治疗靶点。然后,我们采用Transwell、生化试剂盒、实时定量聚合酶链反应(RT-qPCR)和转录组学,研究PAS840对氧糖剥夺/复氧(OGD/R)损伤后小鼠小胶质细胞(BV-2)迁移能力、氧化应激水平和细胞通路的影响。最后,我们使用伊文思蓝染色、免疫组织化学分析和RT-qPCR,研究PAS840对短暂性大脑中动脉闭塞(tMCAO)大鼠模型血脑屏障、炎症通路和神经功能的影响。PAS840成分靶向多个IS通路,有效抑制OGD/R后BV-2细胞中NF-κB/NLRP3/Caspase-1/IL-1β炎性小体通路的激活,降低细胞氧化应激、炎症和焦亡,提高细胞活力和迁移能力。PAS840降低tMCAO大鼠脑中NF-κB/NLRP3/Caspase-1/IL-1β炎性小体通路的表达,减轻炎症,激活BDNF/VGF/NGR1/Erbb4神经营养因子和血管内皮生长因子通路,增强神经元细胞活力,并有效保护和修复血脑屏障。